Key result
ECMO in pregnancy carries ~31% in-hospital mortality, especially when indicated for cardiogenic shock.
Why the study?
Prior large database reviews of ECMO use in the peripartum population did not stratify by ECMO indication nor include obstetric conditions such as preeclampsia.
Cohort (n=59)
Yes
ECMO use in pregnant patients is rare but carries a high in-hospital mortality rate of 30.5%, which is significantly increased when indicated for cardiogenic shock.
May inform risk discussions for pregnant ECMO candidates; leaves open whether indication-specific protocols improve survival pending prospective data.
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is increasingly used in patients with severe cardiorespiratory collapse. Although prior large database reviews of ECMO use in the peripartum population exist, they do not stratify by ECMO indication nor do they include obstetric conditions such as preeclampsia. Our objective was to characterize the incidence, indication-associated mortality, and factors associated with mortality in pregnant patients who underwent ECMO. METHODS: We examined the United States National Inpatient Sample database to identify hospitalizations for pregnancy from January 1, 2010 to December 31, 2016. We identified pregnant patients who underwent ECMO using International Classification of Diseases ninth and tenth revisions codes. The primary outcome was in-hospital all-cause mortality across pregnant patients who underwent ECMO for any indication. We evaluated the indication for ECMO, incidence, prevalence of risk factors, comorbidities and conditions, and their association with in-hospital mortality. RESULTS: Fifty-nine of 5'346,517 pregnant patients underwent ECMO during our study period (incidence, 1.1; 95% confidence interval [CI], 0.84-1.4 per 100,000 hospitalizations). Indications for ECMO support included respiratory failure (79.7%), cardiogenic shock (64.4%), or circulatory arrest (25.4%). Most patients (57.6%) had more than 1 indication. The overall in-hospital mortality rate was 30.5%. Mortality was 29.8% in patients with respiratory failure, 39.5% with cardiogenic shock, 46.7% with cardiac arrest, and 42.4% in those with combined diagnoses. Cardiogenic shock was associated with a significantly higher mortality rate and adjusted odds ratio 5.0 (95% CI, 1.25-27.0). Most patients (62.7%) had one or more comorbidities. CONCLUSIONS: The frequency of ECMO use across the pregnant population was low over this time period, with a mortality rate of 1 in 3 patients. Mortality was greatest in patients with cardiogenic shock. Further work is needed to understand how best to improve ECMO outcomes in pregnant patients.
No takes yet. Share an insight, caveat, or question.
Bosch et al. (2022) conducted a cohort in Pregnant patients requiring extracorporeal membrane oxygenation (ECMO) (n=59). Extracorporeal membrane oxygenation (ECMO) was evaluated on In-hospital all-cause mortality (95% CI 19.1-43.9). In pregnant patients undergoing extracorporeal membrane oxygenation, the overall in-hospital mortality rate was 30.5%, with cardiogenic shock as an indication associated with a significantly higher mortality risk (aOR 5.0).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: